- 全部删除
您的购物车当前为空
SN50 TFA 是一种细胞通透性 NF-κB 抑制剂,通过抑制 NF-κB p65 易位减轻急性呼吸窘迫综合征小鼠的肺泡高凝状态和纤溶抑制。SN50 TFA 可用于 ARDS 的研究。

SN50 TFA 是一种细胞通透性 NF-κB 抑制剂,通过抑制 NF-κB p65 易位减轻急性呼吸窘迫综合征小鼠的肺泡高凝状态和纤溶抑制。SN50 TFA 可用于 ARDS 的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 μg | ¥ 1,690 | 35日内发货 | |
| 1 mg | ¥ 3,230 | 35日内发货 | |
| 5 mg | ¥ 13,300 | 35日内发货 |
SN50 TFA 相关产品
| 产品描述 | SN50 TFA is a cell-permeable inhibitor of NF-κB and attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation. SN50 TFA can be used in studies about ARDS. |
| 别名 | SN50 三氟乙酸盐, SN50 trifluoroacetate, SN50 TFA (213546-53-3 free base), NF-κB Inhibitor TFA |
| 分子量 | 2781.5 (free base) |
| 分子式 | C129H230N36O29S.XCF3COOH |
| Smiles | [H]N[C@H](C(N[C@H](C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N1CCC[C@H]1C(N[C@H](C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@H](C(N2CCC[C@H]2C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@H](C(N3CCC[C@H]3C(O)=O)=O)CCSC)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C)=O)=O)=O)C)=O)=O)=O)=O)C)=O)=O)=O)=O)C)=O)=O)C)=O)C.OC(C(F)(F)F)=O |
| Sequence | H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH |
| Sequence Short | AAVALLPAVLLALLAPVQRKRQKLMP |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMF: 30 mg/mL, Sonication is recommended. PBS (pH 7.2): 5 mg/mL, Sonication is recommended. DMSO: 30 mg/mL, Sonication is recommended. Ethanol: 50 mg/mL, Sonication is recommended. |
评论内容